These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 29161077)

  • 1. Mitochondrial Dysfunction in Pulmonary Fibrosis.
    Rangarajan S; Bernard K; Thannickal VJ
    Ann Am Thorac Soc; 2017 Nov; 14(Supplement_5):S383-S388. PubMed ID: 29161077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.
    Mora AL; Bueno M; Rojas M
    J Clin Invest; 2017 Feb; 127(2):405-414. PubMed ID: 28145905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
    Pardo A; Selman M
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular metabolomics of pulmonary fibrosis, from amino acids to lipids.
    Roque W; Romero F
    Am J Physiol Cell Physiol; 2021 May; 320(5):C689-C695. PubMed ID: 33471621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis.
    Bueno M; Calyeca J; Rojas M; Mora AL
    Redox Biol; 2020 Jun; 33():101509. PubMed ID: 32234292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis.
    Parimon T; Hohmann MS; Yao C
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis.
    Parimon T; Yao C; Stripp BR; Noble PW; Chen P
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32218238
    [No Abstract]   [Full Text] [Related]  

  • 8. The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis.
    Nuovo GJ; Hagood JS; Magro CM; Chin N; Kapil R; Davis L; Marsh CB; Folcik VA
    Mod Pathol; 2012 Mar; 25(3):416-33. PubMed ID: 22037258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction and chronic lung disease.
    Fang T; Wang M; Xiao H; Wei X
    Cell Biol Toxicol; 2019 Dec; 35(6):493-502. PubMed ID: 31119467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Senescence: The Trojan Horse in Chronic Lung Diseases.
    Hamsanathan S; Alder JK; Sellares J; Rojas M; Gurkar AU; Mora AL
    Am J Respir Cell Mol Biol; 2019 Jul; 61(1):21-30. PubMed ID: 30965013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis.
    Mümmler C; Burgy O; Hermann S; Mutze K; Günther A; Königshoff M
    FASEB J; 2018 Feb; 32(2):703-716. PubMed ID: 28986417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model.
    Selman M; Pardo A
    Am J Respir Crit Care Med; 2014 May; 189(10):1161-72. PubMed ID: 24641682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis.
    Chung KP; Hsu CL; Fan LC; Huang Z; Bhatia D; Chen YJ; Hisata S; Cho SJ; Nakahira K; Imamura M; Choi ME; Yu CJ; Cloonan SM; Choi AMK
    Nat Commun; 2019 Jul; 10(1):3390. PubMed ID: 31358769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alveolar Epithelial Type 2 Cell Dysfunction in Idiopathic Pulmonary Fibrosis.
    Zhu W; Tan C; Zhang J
    Lung; 2022 Oct; 200(5):539-547. PubMed ID: 36136136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Quality Control in Age-Related Pulmonary Fibrosis.
    Roque W; Cuevas-Mora K; Romero F
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic links between aging and lung fibrosis.
    Thannickal VJ
    Biogerontology; 2013 Dec; 14(6):609-15. PubMed ID: 23929205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3: a central mediator of pulmonary fibrosis?
    Prêle CM; Yao E; O'Donoghue RJ; Mutsaers SE; Knight DA
    Proc Am Thorac Soc; 2012 Jul; 9(3):177-82. PubMed ID: 22802294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latest progress on the molecular mechanisms of idiopathic pulmonary fibrosis.
    Fang Y; Tian J; Fan Y; Cao P
    Mol Biol Rep; 2020 Dec; 47(12):9811-9820. PubMed ID: 33230784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis.
    Bueno M; Lai YC; Romero Y; Brands J; St Croix CM; Kamga C; Corey C; Herazo-Maya JD; Sembrat J; Lee JS; Duncan SR; Rojas M; Shiva S; Chu CT; Mora AL
    J Clin Invest; 2015 Feb; 125(2):521-38. PubMed ID: 25562319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.
    Wygrecka M; Didiasova M; Berscheid S; Piskulak K; Taborski B; Zakrzewicz D; Kwapiszewska G; Preissner KT; Markart P
    Thromb Haemost; 2013 Aug; 110(2):295-307. PubMed ID: 23739922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.